Issue Information.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 249, doi. 10.1002/1878-0261.12002
- Publication type:
- Article
Works matching IS 15747891 AND DT 2017 AND VI 11 AND IP 3
Results: 7
1
2
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 251, doi. 10.1002/1878-0261.12030
- By:
- Publication type:
- Article
3
TRIM8 regulates stemness in glioblastoma through PIAS3- STAT3.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 280, doi. 10.1002/1878-0261.12034
- By:
- Publication type:
- Article
4
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 295, doi. 10.1002/1878-0261.12037
- By:
- Publication type:
- Article
5
Dysregulation of the miR-194- CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 305, doi. 10.1002/1878-0261.12038
- By:
- Publication type:
- Article
6
Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 320, doi. 10.1002/1878-0261.12039
- By:
- Publication type:
- Article
7
Sorafenib analogue SC-60 induces apoptosis through the SHP-1/ STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 266, doi. 10.1002/1878-0261.12033
- By:
- Publication type:
- Article